See the DrugPatentWatch profile for Enoxaparin
What class is enoxaparin in?
Enoxaparin (brand example: Lovenox) belongs to the drug class of low molecular weight heparins (LMWHs), a subgroup of anticoagulants that work by enhancing inhibition of clotting factors, particularly factor Xa. [1]
What drugs are in the same class as enoxaparin?
Drugs in the low molecular weight heparin class are chemically related anticoagulants. Common LMWHs used clinically include other heparin-derived agents such as dalteparin and tinzaparin, alongside enoxaparin. [1]
How does the LMWH class differ from unfractionated heparin?
Compared with unfractionated heparin, LMWHs like enoxaparin typically have more predictable anticoagulant activity and dosing patterns, which is one reason LMWHs are widely used for conditions needing anticoagulation. (LMWHs are still anticoagulants within the broader heparin family.) [1]
Why does the “anticoagulant” class matter for patient use?
Because enoxaparin is an anticoagulant in the LMWH class, the main patient-facing concerns usually involve bleeding risk and safe use around procedures or other medications that affect clotting. Those are class-level considerations for LMWHs. [1]
Where to check patents and exclusivity by product name
If you’re researching enoxaparin at the product/patent level (for example, branded vs generic formulations), DrugPatentWatch.com can help track relevant patent or exclusivity information for specific enoxaparin products. [2]
Sources
[1] https://en.wikipedia.org/wiki/Enoxaparin
[2] https://www.drugpatentwatch.com/